- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 2.2 Side Letter to Business Combination Agreement, Dated November 32, 2022, by and Among Larkspur Health Acquisition Corp., Larkspur Merger Sub Inc., Stephen Glover and Zyversa Therapeutics, Inc
- 3.6 Form of Certificate of Designation of Larkspur Health Acquisition Corp. Relating to the Series B Convertible Preferred Stock
- 5.1 Opinion of Alston & Bird LLP As to the Validity of the Shares of Common Stock and Warrants
- 8.1 Tax Opinion of Lowenstein Sandler LLP
- 10.19 Form of Amendment #1 to the Securities Purchase Agreement, by and Among Larkspur Health Acquisition Corp. and Each Purchaser Identified on the Signature Pages Thereto
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Larkspur Health Acquisition Corp
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Zyversa Therapeutics, Inc
- 99.6 Consent of Cassel Salpeter & Co., LLC
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
- 15 Nov 22 EFFECT Notice of effectiveness
- 14 Nov 22 424B3 Prospectus supplement
-
3 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 20 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 Aug 22 S-4 Registration of securities issued in business combination transactions
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Larkspur Health Acquisition Corp. (the “Company”) on Amendment No. 3 to Form S-4 of our report dated April 14, 2022, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the financial statements of Larkspur Health Acquisition Corp. as of December 31, 2021 and for the period from March 17, 2021 (inception) through December 31, 2021, which report appears in the Proxy Statement/Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Proxy Statement/Prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
November 3, 2022